HIV and Aging: (Volume-42 Interdisciplinary Topics in Gerontology and Geriatrics)

HIV and Aging (Interdisciplinary Topics in Gerontology and Geriatrics, Volume 42)

HIV and Aging is an interdisciplinary scientific volume that explores the complex interaction between human immunodeficiency virus (HIV) infection and the biological processes of aging. As part of the Interdisciplinary Topics in Gerontology and Geriatrics series, this book provides a comprehensive overview of clinical, molecular, and social dimensions of managing older adults living with HIV. With advances in antiretroviral therapy, HIV infection has transitioned from a fatal disease to a chronic manageable condition, leading to a growing population of elderly individuals living with the virus.

The central theme of the book is the convergence of HIV pathophysiology with age-related biological decline. Aging and chronic HIV infection share several mechanistic pathways including immune dysregulation, chronic inflammation, mitochondrial dysfunction, and increased vulnerability to comorbid diseases. Understanding these interactions is essential for improving long-term outcomes and quality of life in older HIV-positive patients.

One of the primary topics discussed is immune system aging, often referred to as immunosenescence. As individuals age, the immune system undergoes structural and functional decline characterized by reduced T-cell proliferation, impaired antigen recognition, and decreased vaccine responsiveness. HIV infection accelerates this process by targeting CD4+ T lymphocytes and disrupting immune signaling networks. Even with successful viral suppression using antiretroviral therapy, immune restoration is often incomplete, resulting in persistent immune activation.

Chronic inflammation is another critical focus of the volume. Many older patients with HIV exhibit a state of persistent low-grade inflammation sometimes described as “inflammaging.” Elevated inflammatory cytokines contribute to endothelial dysfunction, atherosclerosis, and metabolic disturbances. The book explains how viral reservoirs and residual immune activation sustain inflammatory pathways despite pharmacological control of viral replication.

Neurological complications associated with HIV and aging are also extensively reviewed. Cognitive decline, neurodegeneration, and neuropsychiatric disorders occur more frequently in elderly HIV patients. HIV-associated neurocognitive disorders may arise from viral invasion of the central nervous system, chronic inflammation, and mitochondrial toxicity induced by certain antiretroviral drugs. Early detection and cognitive monitoring are emphasized as important components of clinical management.

Metabolic disorders represent another major clinical challenge. Older adults with HIV have increased prevalence of insulin resistance, dyslipidemia, and cardiovascular disease. The book discusses how both HIV infection and long-term antiretroviral therapy contribute to metabolic dysfunction. Protease inhibitors and other drug classes can alter lipid metabolism and promote visceral fat accumulation, increasing cardiovascular risk.

Polypharmacy is a significant concern in geriatric HIV care. Elderly patients often require treatment for multiple comorbid conditions such as hypertension, diabetes, osteoporosis, and neurodegenerative disease. The volume emphasizes careful medication review to avoid adverse drug interactions, particularly because many antiretroviral agents share metabolic pathways with commonly prescribed geriatric medications.

Bone health is another important subject. HIV infection is associated with reduced bone mineral density and increased fracture risk. Contributing factors include chronic inflammation, vitamin D deficiency, lifestyle factors, and effects of antiretroviral therapy on bone metabolism. Screening for osteoporosis and implementing preventive strategies such as calcium supplementation, vitamin D optimization, and weight-bearing exercise are recommended.

The psychosocial dimensions of aging with HIV are also explored. Stigma, social isolation, depression, and economic challenges disproportionately affect elderly individuals living with HIV. The book highlights the importance of multidisciplinary care models that integrate medical treatment with psychological and social support services.

Special attention is given to cancer risk. Older HIV-positive individuals have higher incidence of certain malignancies, including lymphomas and Kaposi sarcoma. Chronic immune suppression and viral oncogenesis are considered key contributing factors. Regular cancer screening and early diagnostic evaluation are strongly advocated.

Therapeutic strategies for elderly HIV patients require individualized approaches. Antiretroviral therapy must be optimized to maintain viral suppression while minimizing toxicity. Drug selection should consider renal function, hepatic metabolism, and potential interactions with age-related physiological changes. The concept of geriatric assessment is increasingly incorporated into HIV treatment planning.

Future research directions highlighted in the volume include immune rejuvenation strategies, development of safer antiretroviral drugs, and exploration of biomarkers for biological aging in HIV patients. Advances in precision medicine may enable more personalized treatment regimens tailored to both viral and host aging characteristics.

Overall, HIV and Aging (Interdisciplinary Topics in Gerontology and Geriatrics, Volume 42) provides a multidisciplinary perspective on one of the most important emerging challenges in modern medicine. By integrating immunology, geriatrics, neurology, and public health, the book serves as a valuable resource for clinicians, researchers, and healthcare professionals managing the growing population of older adults living with HIV.